Author Correction: Investigation of Cas9 antibodies in the human eye
Nat Commun
.
2022 Apr 12;13(1):2109.
doi: 10.1038/s41467-022-29844-x.
Authors
Marcus A Toral
1
2
,
Carsten T Charlesworth
3
,
Benjamin Ng
1
4
,
Teja Chemudupati
1
,
Shota Homma
5
,
Hiromitsu Nakauchi
5
6
7
,
Alexander G Bassuk
8
,
Matthew H Porteus
9
,
Vinit B Mahajan
10
11
Affiliations
1
Molecular Surgery Program, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
2
Medical Scientist Training Program and Graduate Program in Molecular Medicine, University of Iowa, Iowa City, IA, USA.
3
Department of Pediatrics, Stanford University, Palo Alto, CA, USA.
4
Medical Sciences Division, University of Oxford, Oxford, UK.
5
Department of Genetics, Stanford University, Palo Alto, CA, USA.
6
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
7
Division of Stem Cell Therapy, Distinguished Professor Unit, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
8
Departments of Pediatrics and Neurology and The Iowa Neuroscience Institute (INI), University of Iowa, Iowa City, IA, USA.
9
Department of Pediatrics, Stanford University, Palo Alto, CA, USA. mporteus@stanford.edu.
10
Molecular Surgery Program, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA, USA. vinit.mahajan@stanford.edu.
11
Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, Palo Alto, CA, USA. vinit.mahajan@stanford.edu.
PMID:
35414059
PMCID:
PMC9005661
DOI:
10.1038/s41467-022-29844-x
No abstract available
Publication types
Published Erratum
Grant support
P30 EY026877/EY/NEI NIH HHS/United States
T32 GM139776/GM/NIGMS NIH HHS/United States